CYBB and COVID-19: Indeed, a higher NOX-2 activation was observed in patients with thrombotic complications as compared to event-free patients, suggesting that NOX-2-derived oxidative stress contributed to the pathophysiology of COVID-19 cardiovascular sequelae [57].